Jennifer L Davis will succeed Joseph M Hogan as president and chief executive officer of Align Technology at the end of 2026.

Align Technology Inc., the global medical device company best known for the Invisalign system, has officially announced a significant leadership transition. Jennifer L. Davis, a seasoned executive with over three decades of experience in the consumer healthcare sector, has been named the company’s incoming president and CEO. She is scheduled to assume the role on December 31, 2026, marking the end of Joseph M. Hogan’s tenure, which began in 2015. This transition is part of a deliberate succession plan designed to ensure continuity and strategic evolution for the dental technology giant.

The Strategic Leadership Transition Timeline

The transition process is structured to facilitate a smooth handover of responsibilities between the outgoing and incoming leaders. According to the company’s formal announcement, the timeline is as follows:

• November 2, 2026: Jennifer L. Davis will join Align Technology as CEO-elect. At this juncture, she will also be appointed as a member of the company’s board of directors, allowing her to gain institutional familiarity and engage with the executive team.
• December 31, 2026: Jennifer L. Davis will officially assume the roles of president and chief executive officer, succeeding Joseph M. Hogan.
• June 16, 2027: Joseph M. Hogan will conclude his service on the board of directors following a final strategy meeting, effectively ending his long-term formal association with the firm’s governance.

This phased approach underscores the company’s commitment to maintaining its market position during a period of significant technological advancement in the orthodontics industry.

Background and Professional Pedigree of Jennifer L. Davis

Davis arrives at Align Technology following a distinguished 33-year career at Procter & Gamble (P&G). Her most recent role as chief executive officer of P&G’s global healthcare business provides a clear indicator of why the Align board identified her as the ideal successor. Her responsibilities at P&G included overseeing a vast, multibillion-dollar portfolio of brands within the oral-health and personal-health sectors.

Her expertise in consumer-healthcare strategy, innovation management, and large-scale operations is expected to be a primary asset for Align. As the company moves to further cement the Invisalign brand as a household name and expand its footprint in the broader digital oral health market, Davis’s experience in navigating the complexities of consumer trust and clinical efficacy will be central to her leadership mandate.

Joseph M. Hogan’s Legacy at Align Technology

Joseph M. Hogan’s departure marks the end of an era for the Tempe-based company. Since taking the helm in 2015, Hogan has presided over a period of unprecedented growth and transformation. Under his leadership, Align Technology evolved from a clear-aligner manufacturer into a comprehensive digital orthodontics platform.

Hogan was instrumental in the integration of the iTero intraoral scanner and the acquisition and development of exocad software, which collectively form the "Align Digital Platform." During his tenure, the company significantly expanded its reach, navigating the challenges of the global pandemic while scaling production capabilities to meet surging demand for clear aligner therapy. His departure is widely viewed as a planned retirement, and he leaves the company with a market capitalization and operational reach vastly different from when he first joined.

Data-Driven Context: The Evolution of Digital Dentistry

To understand the magnitude of this transition, one must consider the market position Align Technology currently holds. The company has moved beyond simple dental aesthetics into high-tech digital workflows. According to recent market reports, the global clear aligner market has seen a compound annual growth rate (CAGR) in the double digits, a trend heavily influenced by the adoption of digital imaging and 3D printing—technologies that Align has championed.

In 2023 and early 2024, Align reported that it had treated over 17 million patients globally with the Invisalign system. The company’s focus has increasingly shifted toward "Digital Orthodontics," which integrates patient assessment, treatment planning, and manufacturing via cloud-based software. Davis will be expected to maintain this trajectory, balancing the company’s dual identity as both a medical device manufacturer and a software-driven digital platform provider.

Official Responses and Strategic Outlook

The sentiment from the board of directors is one of calculated confidence. Kevin Conroy, chairman of the board, highlighted that Davis’s background provides the specific cross-functional expertise needed for the next phase of the company’s journey. By merging her consumer-healthcare insights with Align’s existing strengths in clinical science and software engineering, the company aims to deepen its relationship with dental practitioners and expand the accessibility of its technology.

Joseph M. Hogan reflected on his tenure with a sense of accomplishment, noting the strength of the current leadership team. In a prepared statement, he expressed his belief that the company’s "innovation engine" and established trust with doctors provide a stable foundation for the future.

Davis, in her own comments, emphasized the importance of stakeholder engagement. "The company has transformed orthodontics and dentistry through technology, clinical excellence, and deep partnerships with doctors," Davis stated. She highlighted her intention to prioritize learning from the company’s internal teams and, perhaps most crucially, listening to the feedback from the doctors who act as the frontline users of the Invisalign and iTero systems.

Implications for the Future: Challenges and Opportunities

The appointment of a new CEO brings both continuity and the potential for a fresh strategic lens. Industry analysts suggest that the core challenge for Davis will be navigating the increased competition in the clear aligner space. While Align remains the market leader, the expiration of key patents and the emergence of lower-cost, direct-to-consumer alternatives have forced a shift in strategy.

Align’s strategy has been to distinguish itself through "clinical excellence"—the idea that the Invisalign system is not merely a piece of plastic but a highly engineered medical device supported by proprietary software that requires the oversight of a trained professional. Davis’s history at P&G suggests that she is well-equipped to manage this brand positioning. P&G’s business model is built on consumer loyalty and brand equity, which aligns well with Align’s goal of making Invisalign the preferred choice for patients seeking orthodontic treatment.

Furthermore, the expansion of the Align Digital Platform into broader restorative dentistry—specifically through its exocad integration—represents a massive growth opportunity. By moving beyond orthodontics and into general and restorative dental workflows, the company is attempting to capture a larger share of the dental office’s technology budget. Davis will likely be tasked with accelerating this integration, ensuring that the software remains the central nervous system of the modern dental practice.

Corporate Governance and Stability

The early announcement of this transition—more than a year before the change of command—is a hallmark of strong corporate governance. By providing the market and the employees with a clear timeline, Align Technology minimizes the risk of instability that often accompanies executive changes. The board’s decision to keep Hogan on the board until mid-2027 ensures that his institutional knowledge remains accessible during the initial months of the Davis administration.

As the company prepares for this transition, shareholders and dental practitioners alike will be watching for signals regarding any potential shifts in operational priorities. However, for now, the message from the boardroom is clear: the focus remains on leveraging the existing innovation pipeline to maintain market dominance in the face of an increasingly digital and automated dental landscape.

In summary, the transition from Hogan to Davis represents a shift from a period of aggressive scaling and platform building to one that may prioritize consumer-driven growth and the solidification of the brand’s global footprint. With her deep experience in consumer healthcare, Jennifer L. Davis is positioned to guide Align Technology through its next chapter, navigating the dual demands of clinical precision and the rapid digitization of the healthcare industry.